News from wuxi pharmatech co. ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 04, 2015, 08:00 ET

WuXi AppTec Partners with Fudan University and the Collaborative Innovation Center of Genetics and Development

WuXi AppTec today announced a partnership with Fudan University to bring WuXi NextCODE's world-leading population human genomics database system...

May 21, 2015, 19:00 ET

Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx

A consortium ("the Consortium") consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China...

May 21, 2015, 08:00 ET

WuXi Launches e-Commerce Platform for Chemistry Products

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the...

May 13, 2015, 16:30 ET

WuXi PharmaTech Announces First-Quarter 2015 Results

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

May 13, 2015, 08:00 ET

WuXi PharmaTech Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

WuXi PharmaTech (Cayman) Inc. ("WuXi" or the "Company") (NYSE:WX), a leading global contract R&D services provider, today announced that,...

Apr 30, 2015, 08:00 ET

WuXi Biologics Begins Construction of the World's Largest Mammalian Cell Culture Manufacturing Facility Using Disposable Bioreactors

WuXi Biologics, a wholly owned subsidiary of WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and...

Apr 30, 2015, 07:00 ET

WuXi PharmaTech Announces Receipt of Proposal

WuXi PharmaTech (Cayman) Inc. ("WuXi" or the "Company") (NYSE:WX), a leading global contract R&D services provider, today announced that its...

Apr 23, 2015, 10:44 ET

WuXi PharmaTech Schedules First-Quarter 2015 Earnings Release

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Apr 22, 2015, 07:00 ET

Big Data and Genomics Meet the Cloud: the First Unified Global Platform for Precision Medicine

SHANGHAI; CAMBRIDGE, Mass.; and MOUNTAIN VIEW, Calif., April 22, 2015 /PRNewswire/ – WuXi PharmaTech (Cayman) Inc. (NYSE: WX), whose leading...

Apr 15, 2015, 08:01 ET

WuXi PharmaTech Files 2014 Annual Report on Form 20-F

WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2014, with...

Apr 08, 2015, 08:00 ET

Nobel Prize Laureate Professor Barry Sharpless Visits WuXi AppTec Headquarters in Shanghai

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Apr 02, 2015, 08:30 ET

WuXi PharmaTech Lists Shares of Small-Molecule Manufacturing Subsidiary STA on New Third Board in China

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Mar 27, 2015, 08:00 ET

Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the global...

Mar 12, 2015, 08:20 ET

WuXi PharmaTech To Build New Cell Therapy Manufacturing Facility for CAR T Cells and Other Cancer Immunotherapies

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Mar 05, 2015, 16:30 ET

WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Feb 27, 2015, 17:04 ET

WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Feb 17, 2015, 08:00 ET

WuXi PharmaTech Enters into Syndicated Loan Agreement

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Feb 13, 2015, 08:20 ET

WuXi PharmaTech Schedules Fourth-Quarter 2014 Earnings Release

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Feb 06, 2015, 09:25 ET

WuXiPRA Appoints Two Key Executives

WuXiPRA, a leading clinical services company with operations in the greater China region, today announced appointments of two key executives....

Jan 30, 2015, 08:00 ET

WuXi PharmaTech's Small-Molecule Manufacturing Subsidiary STA Wins CMO Leadership Award

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...